Ligand Pharmaceuticals (LGND) Insider: Stock Move Analysis
A Ligand Pharmaceuticals insider recently sold 5,000 shares, triggering discussions about what insider moves signal f...
Indices rise and fall as growth, inflation, and risk appetite shift; news and expectations reshape valuation baselines and asset flows.
21,301 articlesA Ligand Pharmaceuticals insider recently sold 5,000 shares, triggering discussions about what insider moves signal f...
A new program from Morgan Stanley allows eligible wealth clients to lend crypto to Galaxy Digital in exchange for spo...
A sharp Friday drop in the Teucrium 2x Long Daily XRP ETF underscores how daily-reset leverage can amplify losses in ...
Kris Zacuto has joined Christie’s International Real Estate Southern California as director of luxury estates, bringi...
Bitcoin has shown dramatic swings, but understanding downside helps you invest smarter. This guide breaks down what '...
Public blunders can impact more than pride—they can touch endorsements, streaming dollars, and future opportunities. ...
Investors read rising short-term yields and a cautious long end as the June FOMC nears, signaling how the trillion me...
Insider moves can spark questions about a stock's future. This guide breaks down what insw sold discretionary shares ...
Private markets are stuck in a funding logjam, with longer waiting times and shrinking payouts, signaling that the ci...
Traders expect a policy pivot in guidance rather than a rate move, sparking a fresh warsh trade coming strategy focus...
A bipartisan House bill seeks to cut red tape in Buy America housing funding, aiming to speed projects that rely on H...
As UAD 3.6 rolls out, lenders should view reset as a strategic inflection point — a chance to retool data, adjust ris...